These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 19663632)
41. Networking in Circulation: Lipoproteins, PM20D1, and N-acyl Amino Acid Bioactivity. Saghatelian A Cell Chem Biol; 2020 Sep; 27(9):1112-1113. PubMed ID: 32946756 [TBL] [Abstract][Full Text] [Related]
42. [DRUGS FROM THE STANDPOINT OF METABOLISM]. YONEYAMA Y Sogo Rinsho; 1963 Oct; 12():1795-9. PubMed ID: 14092520 [No Abstract] [Full Text] [Related]
43. Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet-Pharmacotherapy Interactions. Marinescu SCN; Apetroaei MM; Nedea MII; Arsene AL; Velescu BȘ; Hîncu S; Stancu E; Pop AL; Drăgănescu D; Udeanu DI Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674903 [TBL] [Abstract][Full Text] [Related]
44. Assessment of glibenclamide pharmacokinetics in poloxamer 407-induced hyperlipidemic rats. Bin Jardan YA; Ahad A; Raish M; Ahmad A; Alam MA; Al-Mohizea AM; Al-Jenoobi FI Saudi Pharm J; 2021 Jul; 29(7):719-723. PubMed ID: 34400867 [TBL] [Abstract][Full Text] [Related]
46. The effect of increased lipoproteins levels on the disposition of vincristine in rat. Khalil HA; Belal TS; El-Yazbi AF; Hamdy DA Lipids Health Dis; 2016 Sep; 15(1):152. PubMed ID: 27613245 [TBL] [Abstract][Full Text] [Related]
47. Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase. Bakala-N'Goma JC; Williams HD; Sassene PJ; Kleberg K; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Müllertz A; Pouton CW; Porter CJ; Carrière F Pharm Res; 2015 Apr; 32(4):1279-87. PubMed ID: 25288015 [TBL] [Abstract][Full Text] [Related]
48. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations. Williams HD; Sassene P; Kleberg K; Calderone M; Igonin A; Jule E; Vertommen J; Blundell R; Benameur H; Müllertz A; Pouton CW; Porter CJ; Pharm Res; 2013 Dec; 30(12):3059-76. PubMed ID: 23661145 [TBL] [Abstract][Full Text] [Related]
49. Investigation into the cancer protective effect of flaxseed in Tg.NK (MMTV/c-neu) mice, a murine mammary tumor model. Birkved FK; Mortensen A; Peñalvo JL; Lindecrona RH; Sørensen IK Genes Nutr; 2011 Nov; 6(4):403-11. PubMed ID: 21484161 [TBL] [Abstract][Full Text] [Related]
50. Cytochrome P450-mediated metabolism in the human gut wall. Thelen K; Dressman JB J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992 [TBL] [Abstract][Full Text] [Related]
51. [The lipid metabolism of the small intestine and its correlation to the lipid and lipoprotein metabolism of the total organism]. Gangl A Acta Med Austriaca Suppl; 1975; 2():1-49. PubMed ID: 1065179 [TBL] [Abstract][Full Text] [Related]
52. Nutritional parameters that alter hepatic drug metabolism, conjugation, and toxicity. Bidlack WR; Brown RC; Mohan C Fed Proc; 1986 Feb; 45(2):142-8. PubMed ID: 3510912 [TBL] [Abstract][Full Text] [Related]
54. The effect of oral lipids and circulating lipoproteins on the metabolism of drugs. Patel JP; Brocks DR Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1385-98. PubMed ID: 19663632 [TBL] [Abstract][Full Text] [Related]